Notice Title

Consent to the Distribution of New Medicines

Publication Date
30 Jun 2026

Tags

Medicines Act Consent to the distribution of new medicines Health

Notice Number

2026-sl3575
Title
View PDF
File Type and Size
PDF (27 KB)

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product: Dabigatran etexilate ADVZ
Active Ingredient: Dabigatran etexilate mesylate 86.48mg equivalent to dabigatran etexilate 75mg
Dosage Form: Capsule
New Zealand Sponsor: Boucher & Muir (New Zealand) Limited t/a Mercury Pharma (NZ)
Manufacturer: Optimus Pharma Pvt. Limited, Patancheru, India
   
Product: Dabigatran etexilate ADVZ
Active Ingredient: Dabigatran etexilate mesylate 126.83mg equivalent to dabigatran etexilate 110mg
Dosage Form: Capsule
New Zealand Sponsor: Boucher & Muir (New Zealand) Limited t/a Mercury Pharma (NZ)
Manufacturer: Optimus Pharma Pvt. Limited, Patancheru, India
   
Product: Dabigatran etexilate ADVZ
Active Ingredient: Dabigatran etexilate mesylate 172.95mg equivalent to dabigatran etexilate 150mg
Dosage Form: Capsule
New Zealand Sponsor: Boucher & Muir (New Zealand) Limited t/a Mercury Pharma (NZ)
Manufacturer: Optimus Pharma Pvt. Limited, Patancheru, India
   
Product: Ivermectin ADVZ
Active Ingredient: Ivermectin 3mg
Dosage Form: Tablet
New Zealand Sponsor: Boucher & Muir (New Zealand) Limited t/a Mercury Pharma (NZ)
Manufacturer: Europeenne De Pharmacotechnie - Europhartech, Lempdes, France
   
Product: Nicorette QuickMist Mouthspray
Active Ingredient: Nicotine 13.6mg/mL
Dosage Form: Oral spray
New Zealand Sponsor: JNTL Consumer Health (New Zealand) Limited
Manufacturer: McNeil AB, Helsingborg, Sweden
   
Product: Prasugrel Lupin
Active Ingredient: Prasugrel 5mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Lupin NZ Limited
Manufacturers: Jetpharma SA, Balerna, Switzerland
Neuraxpharm Pharmaceuticals, S.L., Barcelona, Spain
   
Product: Prasugrel Lupin
Active Ingredient: Prasugrel 10mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Lupin NZ Limited
Manufacturers: Jetpharma SA, Balerna, Switzerland
Neuraxpharm Pharmaceuticals, S.L., Barcelona, Spain
   
Product: Pyridostigmine Bromide JAMP
Active Ingredient: Pyridostigmine bromide 60mg
Dosage Form: Tablet
New Zealand Sponsor: JAMP Pharma New Zealand Limited
Manufacturers: Medinfar Manufacturing S.A., Sebal, Portugal
Acme Generics Pvt. Limited, Tehsil Nalagarh, India
   
Product: Rennie
Active Ingredients: Calcium carbonate 680mg
Magnesium carbonate 80mg
Dosage Form: Chewable tablet
New Zealand Sponsor: Bayer New Zealand Limited
Manufacturer: PT Bayer Indonesia, Depok, Indonesia
   
Product: Tremfya (pre-filled syringe)
Active Ingredient: Guselkumab 100mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Janssen-Cilag (New Zealand) Limited
Manufacturer: Cilag AG, Schaffhausen, Switzerland
   
Product: Tremfya (pre-filled pen)
Active Ingredient: Guselkumab 100mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Janssen-Cilag (New Zealand) Limited
Manufacturer: Cilag AG, Schaffhausen, Switzerland
   
Product: Tremfya (vial)
Active Ingredient: Guselkumab 10mg/mL
Dosage Form: Concentrate for infusion
New Zealand Sponsor: Janssen-Cilag (New Zealand) Limited
Manufacturer: Cilag AG, Schaffhausen, Switzerland
   
Product: Vabysmo
Active Ingredient: Faricimab 120mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Roche Products (NZ) Limited
Manufacturer: Vetter Pharma-Fertigung GmbH & Co KG, Ravensburg, Germany


Dated this 26th day of June 2026.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).